Burjeel Holdings, a prominent healthcare provider in the UAE, has partnered with the US-based non-profit Caring Cross to locally produce CAR-T (Chimeric Antigen Receptor T-cell) therapies. This collaboration will lead to a significant reduction in treatment costs for aggressive cancers, such as leukemia and lymphoma, making therapies available at up to 90% less than current...
